Yiwei Yang
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 10%
Papers in
-
- RNA Research and Splicing 3
- Pluripotent Stem Cells Research 3
-
- Lung Cancer Diagnosis and Treatment 6
- Co-authors
- Hassan Lemjabbar‐Alaoui (7 shared papers)Petra C. Buchanan (2 shared papers)Joanna J. Phillips (2 shared papers)Jiuhong Kang (13 shared papers)Vy M. Tran (1 shared paper)Andrew McKinney (1 shared paper)Xin Nie (1 shared paper)Bo Lü (1 shared paper)
- Journals
- Stem Cells (5 papers)Experimental Lung Research (2 papers)Neurotoxicity Research (2 papers)Ecological Indicators (2 papers)Journal of Applied Clinical Medical Physics (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Yiwei Yang
51 papers receiving 1.5k citations
Yiwei Yang's Hit Papers
Peers
Comparison fields: 5 of 141
- Cancer Research 238
- Oncology 229
- Radiation 77
- Pulmonary and Respiratory Medicine 250
- Molecular Biology 548
Countries citing papers authored by Yiwei Yang
This map shows the geographic impact of Yiwei Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiwei Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiwei Yang more than expected).
Fields of papers citing papers by Yiwei Yang
This network shows the impact of papers produced by Yiwei Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiwei Yang. The network helps show where Yiwei Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Yiwei Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lung cancer: Biology and treatment options Hit paper breakdown → | 2015 | 786 |
| 2 | 2020 | 94 | |
| 3 | 2015 | 70 | |
| 4 | 2020 | 69 | |
| 5 | 2016 | 51 | |
| 6 | 2018 | 51 | |
| 7 | 2019 | 48 | |
| 8 | 2017 | 34 | |
| 9 | 2023 | 25 | |
| 10 | 2022 | 18 | |
| 11 | 2020 | 17 | |
| 12 | 2020 | 17 | |
| 13 | AMXI-5001, a novel dual parp1/2 and microtubule polymerization inhibitor for the treatment of human cancers. | 2020 | 16 |
| 14 | 2016 | 15 | |
| 15 | 2018 | 14 | |
| 16 | 2018 | 12 | |
| 17 | 2020 | 11 | |
| 18 | 2020 | 10 | |
| 19 | 2019 | 10 | |
| 20 | 2020 | 9 |
About Yiwei Yang
Yiwei Yang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Radiation, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 55 papers that have together received 1.5k indexed citations. Recurring topics across this work include Advanced Radiotherapy Techniques (7 papers), Cancer-related molecular mechanisms research (6 papers), Lung Cancer Diagnosis and Treatment (6 papers), Head and Neck Cancer Studies (4 papers), MicroRNA in disease regulation (4 papers), RNA Research and Splicing (3 papers), Nematode management and characterization studies (3 papers) and Pluripotent Stem Cells Research (3 papers). The work is most often cited by research in Cancer Research (238 citations), Oncology (229 citations), Radiation (77 citations), Pulmonary and Respiratory Medicine (250 citations) and Molecular Biology (548 citations). Yiwei Yang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Hassan Lemjabbar‐Alaoui, Petra C. Buchanan, Joanna J. Phillips, Jiuhong Kang, Vy M. Tran, Andrew McKinney, Xin Nie, Bo Lü, Xudong Guo and Zhoupeng Chen. Their work appears in journals such as Stem Cells, Experimental Lung Research, Neurotoxicity Research, Ecological Indicators and Journal of Applied Clinical Medical Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.